Consainsights logo
Life Sciences

Prophylactic HIV Drugs Market

Drug, Dosage Form.
License Type
$4750
Need custom report? click here
What you get?
  • Online view only
  • Delivered in 24-72 hours
  • Only a single designated user can access the report
  • 5 hours of analyst support

Executive Summary

Prophylactic HIV Drugs Market from Consainsights analyses the Prophylactic HIV Drugs Market in the Technology & Media industry over the forecast period to 2026.

Prophylactic HIV Drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Prophylactic HIV Drugs segmentation includes Drug, Dosage Form and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Drug, the Prophylactic HIV Drugs Market analysis covers Emtricitabine, Other Drugs, Tenofovir.

Based on the Dosage Form, the Prophylactic HIV Drugs Market analysis covers Oral, Topical.

Key companies operating in the market include ViiV Healthcare Group of Companies, Merck & Co. Inc., Cipla Inc., Auro Pharma Inc., Genentech Inc., Pfizer Inc., GalaxoSmithKline PLC, Gilead Sciences Inc., Johnson & Johnson Health Care Systems Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, APOTEX INC., Mylan NV, AbbVie, Teva Pharmaceutical Industries Ltd and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2012-2027

Base year considered

2021

Forecast period

2022-2027

Forecast units

Value (USD Billion)

Segments covered

Drug, Dosage Form

Geographies covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Companies Covered

ViiV Healthcare Group of Companies, Merck & Co. Inc., Cipla Inc., Auro Pharma Inc., Genentech Inc., Pfizer Inc., GalaxoSmithKline PLC, Gilead Sciences Inc., Johnson & Johnson Health Care Systems Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, APOTEX INC., Mylan NV, AbbVie, Teva Pharmaceutical Industries Ltd

Table of Contents

  1. Executive Summary

  2. Prophylactic HIV Drugs Market Overview

    1. Prophylactic HIV Drugs Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Prophylactic HIV Drugs Market 360° Synopsis: Overview

  3. Prophylactic HIV Drugs Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis

  4. Prophylactic HIV Drugs Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Prophylactic HIV Drugs Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)

  5. Prophylactic HIV Drugs Market: Drug

    1. Introduction
    2. Emtricitabine: Market Trends, Size, and Forecast (2017-2026)
    3. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
    4. Tenofovir: Market Trends, Size, and Forecast (2017-2026)

  6. Prophylactic HIV Drugs Market: Dosage Form

    1. Introduction
    2. Oral: Market Trends, Size, and Forecast (2017-2026)
    3. Topical: Market Trends, Size, and Forecast (2017-2026)

  7. Global Analysis

    1. Global Prophylactic HIV Drugs Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

  8. Latin America Analysis

    1. Latin America Prophylactic HIV Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction

      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Prophylactic HIV Drugs Market: Drug
        3. Brazil Prophylactic HIV Drugs Market: Dosage Form

      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Prophylactic HIV Drugs Market: Drug
        3. Argentina Prophylactic HIV Drugs Market: Dosage Form

      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Prophylactic HIV Drugs Market: Drug
        3. Mexico Prophylactic HIV Drugs Market: Dosage Form

      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Prophylactic HIV Drugs Market: Drug
        3. Colombia Prophylactic HIV Drugs Market: Dosage Form

      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Prophylactic HIV Drugs Market: Drug
        3. Rest of Latin America Prophylactic HIV Drugs Market: Dosage Form

    2. Latin America Prophylactic HIV Drugs Market, By Drug, Y-O-Y Growth Analysis

      1. Introduction
      2. Emtricitabine: Market Trends, Size, and Forecast (2017-2026)
      3. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Tenofovir: Market Trends, Size, and Forecast (2017-2026)

    3. Latin America Prophylactic HIV Drugs Market, By Dosage Form, Y-O-Y Growth Analysis

      1. Introduction
      2. Oral: Market Trends, Size, and Forecast (2017-2026)
      3. Topical: Market Trends, Size, and Forecast (2017-2026)

  9. Europe Analysis

    1. Europe Prophylactic HIV Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction

      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Prophylactic HIV Drugs Market: Drug
        3. Germany Prophylactic HIV Drugs Market: Dosage Form

      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Prophylactic HIV Drugs Market: Drug
        3. United Kingdom Prophylactic HIV Drugs Market: Dosage Form

      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Prophylactic HIV Drugs Market: Drug
        3. France Prophylactic HIV Drugs Market: Dosage Form

      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Prophylactic HIV Drugs Market: Drug
        3. Spain Prophylactic HIV Drugs Market: Dosage Form

      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Prophylactic HIV Drugs Market: Drug
        3. Russia Prophylactic HIV Drugs Market: Dosage Form

      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Prophylactic HIV Drugs Market: Drug
        3. Italy Prophylactic HIV Drugs Market: Dosage Form

      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Prophylactic HIV Drugs Market: Drug
        3. Rest of Europe Prophylactic HIV Drugs Market: Dosage Form

    2. Europe Prophylactic HIV Drugs Market, By Drug, Y-O-Y Growth Analysis

      1. Introduction
      2. Emtricitabine: Market Trends, Size, and Forecast (2017-2026)
      3. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Tenofovir: Market Trends, Size, and Forecast (2017-2026)

    3. Europe Prophylactic HIV Drugs Market, By Dosage Form, Y-O-Y Growth Analysis

      1. Introduction
      2. Oral: Market Trends, Size, and Forecast (2017-2026)
      3. Topical: Market Trends, Size, and Forecast (2017-2026)

  10. Asia-Pacific Analysis

    1. Asia-Pacific Prophylactic HIV Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction

      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Prophylactic HIV Drugs Market: Drug
        3. China Prophylactic HIV Drugs Market: Dosage Form

      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Prophylactic HIV Drugs Market: Drug
        3. Japan Prophylactic HIV Drugs Market: Dosage Form

      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Prophylactic HIV Drugs Market: Drug
        3. India Prophylactic HIV Drugs Market: Dosage Form

      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Prophylactic HIV Drugs Market: Drug
        3. Southeast Asia Prophylactic HIV Drugs Market: Dosage Form

      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Prophylactic HIV Drugs Market: Drug
        3. Australia & New Zealand Prophylactic HIV Drugs Market: Dosage Form

      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Prophylactic HIV Drugs Market: Drug
        3. Rest of Asia-Pacific Prophylactic HIV Drugs Market: Dosage Form

    2. Asia-Pacific Prophylactic HIV Drugs Market, By Drug, Y-O-Y Growth Analysis

      1. Introduction
      2. Emtricitabine: Market Trends, Size, and Forecast (2017-2026)
      3. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Tenofovir: Market Trends, Size, and Forecast (2017-2026)

    3. Asia-Pacific Prophylactic HIV Drugs Market, By Dosage Form, Y-O-Y Growth Analysis

      1. Introduction
      2. Oral: Market Trends, Size, and Forecast (2017-2026)
      3. Topical: Market Trends, Size, and Forecast (2017-2026)

  11. Middle East & Africa Analysis

    1. Middle East & Africa Prophylactic HIV Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction

      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Prophylactic HIV Drugs Market: Drug
        3. Middle East Prophylactic HIV Drugs Market: Dosage Form

      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Prophylactic HIV Drugs Market: Drug
        3. Africa Prophylactic HIV Drugs Market: Dosage Form

      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Prophylactic HIV Drugs Market: Drug
        3. Rest of Middle East & Africa Prophylactic HIV Drugs Market: Dosage Form

    2. Middle East & Africa Prophylactic HIV Drugs Market, By Drug, Y-O-Y Growth Analysis

      1. Introduction
      2. Emtricitabine: Market Trends, Size, and Forecast (2017-2026)
      3. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Tenofovir: Market Trends, Size, and Forecast (2017-2026)

    3. Middle East & Africa Prophylactic HIV Drugs Market, By Dosage Form, Y-O-Y Growth Analysis

      1. Introduction
      2. Oral: Market Trends, Size, and Forecast (2017-2026)
      3. Topical: Market Trends, Size, and Forecast (2017-2026)

  12. North America Analysis

    1. North America Prophylactic HIV Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction

      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Prophylactic HIV Drugs Market: Drug
        3. United States Prophylactic HIV Drugs Market: Dosage Form

      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Prophylactic HIV Drugs Market: Drug
        3. Canada Prophylactic HIV Drugs Market: Dosage Form

    2. North America Prophylactic HIV Drugs Market, By Drug, Y-O-Y Growth Analysis

      1. Introduction
      2. Emtricitabine: Market Trends, Size, and Forecast (2017-2026)
      3. Other Drugs: Market Trends, Size, and Forecast (2017-2026)
      4. Tenofovir: Market Trends, Size, and Forecast (2017-2026)

    3. North America Prophylactic HIV Drugs Market, By Dosage Form, Y-O-Y Growth Analysis

      1. Introduction
      2. Oral: Market Trends, Size, and Forecast (2017-2026)
      3. Topical: Market Trends, Size, and Forecast (2017-2026)

  13. Prophylactic HIV Drugs Market: Company Analysis

    1. Introduction

    2. ViiV Healthcare Group of Companies

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights

    3. Merck & Co. Inc.

    4. Cipla Inc.

    5. Auro Pharma Inc.

    6. Genentech Inc.

    7. Pfizer Inc.

    8. GalaxoSmithKline PLC

    9. Gilead Sciences Inc.

    10. Johnson & Johnson Health Care Systems Inc.

    11. Bristol-Myers Squibb Company

    12. Boehringer Ingelheim International GmbH

    13. APOTEX INC.

    14. Mylan NV

    15. AbbVie

    16. Teva Pharmaceutical Industries Ltd

  14. Prophylactic HIV Drugs Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis

  15. Prophylactic HIV Drugs Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects

  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures & Tables

List of Figures

Figure: Global Prophylactic HIV Drugs Market: Structure

Figure: Global Prophylactic HIV Drugs Market: Value Chain Analysis

Figure: Global Prophylactic HIV Drugs Market: Porter's Five Forces Model

Figure: Global Prophylactic HIV Drugs Market: Market Dynamics

Figure: Global Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: North America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Europe Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Latin America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Global Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: North America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Europe Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Latin America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)

List of Tables

Table: Global Prophylactic HIV Drugs Market, By Drug, 2017-2026 (USD Million)

Table: North America Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: United States Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Canada Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Europe Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Germany Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: United Kingdom Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: France Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Spain Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Russia Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Italy Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Rest of Europe Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Asia-Pacific Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: China Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Japan Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: India Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Southeast Asia Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Australia & New Zealand Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Latin America Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Brazil Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Argentina Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Mexico Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Colombia Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Rest of Latin America Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Middle East & Africa Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Middle East Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Africa Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)

Table: Global Prophylactic HIV Drugs Market, By Dosage Form, 2017-2026 (USD Million)

Table: North America Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: United States Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Canada Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Europe Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Germany Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: United Kingdom Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: France Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Spain Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Russia Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Italy Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Rest of Europe Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Asia-Pacific Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: China Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Japan Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: India Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Southeast Asia Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Australia & New Zealand Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Latin America Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Brazil Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Argentina Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Mexico Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Colombia Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Rest of Latin America Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Middle East & Africa Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Middle East Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Africa Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)